Diagnosing monogenic diabetes: Common misinterpretations of genetic findings

Pediatric Diabetes

Volumn 10, Issue 8, 2009, Pages 497-499

  Rubio Cabezas, Oscar ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; HEMOGLOBIN A1C; INSULIN;

APOPTOSIS; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; EDITORIAL; FAMILY; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INTRON; MATURITY ONSET DIABETES MELLITUS; MONOGENIC DIABETES; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; FAMILY HEALTH; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; NOTE;

DIABETES MELLITUS, TYPE 1; FAMILY HEALTH; GENETICS; HUMANS;

EID: 77449138352     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00560.x     Document Type: Editorial

References (15)

1. Tattersall R. Maturity-onset diabetes of the young: a clinical history. Diabet Med 1998, 15:11-14.
2. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008, 4:200-213.
3. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K. ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006, 7:352-360. International Society for Pediatric and Adolescent Diabetes, Erratum in:, 2007;8:49
4. 2007, http://www.iso15189.com, International Organization for Standardization, (available from
5. 2007, http://www.oecd.org/dataoecd/43/6/38839788.pdf, Guidelines for quality assurance in molecular genetic testing. OECD;, (available from
6. Ellard S, Bellannè-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008, 51:546-553. European Molecular Genetics Quality Network (EMQN) MODY group
7. Odem J, Munzinger E, Violand S, Morlan AV, Rife D, Bachrach B. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age. Pediatr Diabetes 2009, (in press)
8. Macfarlane WM, Frayling TM, Ellard S. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999, 104:R33-R39.
9. Hani EH, Stoffers DA, Chévre JC. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 1999, 104:R41-R48.
10. Elbein SC, Karim MA. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes? Diabetes Care 2004, 27:1968-1973.
11. Gragnoli C, Cronsell J. Meta-analysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population. Minerva Med 2007, 98:163-166.
12. Edghill EL, Flanagan SE, Patch AM. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008, 57:1034-1042.
13. Støy J, Greeley SA, PAZ VP. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008, 9:450-459.
14. Pearson ER, Flechtner I, Njølstad PR. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006, 355:467-477.
15. Rafiq M, Flanagan SE, Patch AM. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008, 31:204-209.